Extensions

Term, Continuation, and Family Data for U.S. Patent No. 12,301,627

Patent Term: Based on the information provided in the patent documentation, U.S. Patent No. 12,301,627 was filed on September 20, 2024, and issued on May 13, 2025. The patent claims priority to an application filed on October 28, 2015 (U.S. Patent Application Ser. No. 14/925,974). Under U.S. patent law, the term of a utility patent is generally 20 years from the earliest non-provisional filing date. Therefore, the anticipated expiration date for this patent is October 28, 2035.

Patent Term Adjustment (PTA) / Patent Term Extension (PTE): A detailed review of the provided patent information does not indicate any Patent Term Adjustment (PTA) or Patent Term Extension (PTE) for U.S. Patent No. 12,301,627. PTA is granted to compensate for delays caused by the U.S. Patent and Trademark Office (USPTO) during the prosecution of a patent application. PTE is a separate provision, typically related to delays in regulatory review for products like pharmaceuticals. Without specific information from the USPTO's records indicating such adjustments, the standard 20-year term from the priority date is assumed.

Continuation and Divisional Applications:

U.S. Patent No. 12,301,627 is a continuation of U.S. Patent Application No. 17/237,346, filed on April 22, 2021. This indicates that the '627 patent is part of an ongoing series of applications that build upon and refine the technology disclosed in earlier filings. The patent's detailed "Cross-Reference to Related Applications" section reveals that it is a continuation-in-part of a long chain of applications, demonstrating a strategic and layered approach to protecting the evolving technology. This extensive family of related applications underscores the value the assignee, Qomplx Inc. (now QOMPLX LLC), places on this area of innovation.

No divisional applications were explicitly identified in the provided documentation for the '627 patent itself. However, given the complexity and breadth of the technology, it is possible that other applications in the family have been divided to cover different aspects of the invention.

Patent Family:

U.S. Patent No. 12,301,627 is part of a large and intricate patent family, as evidenced by the extensive list of related applications in its specification. This family-building strategy is common for technologies that are developed and enhanced over time. The "Cross-Reference to Related Applications" section details the lineage, showing a clear progression from foundational concepts to the more specific applications claimed in the '627 patent.

Key patents in this family, which trace the development of the technology, include:

• U.S. Patent No. 11,025,674: "Cybersecurity Profiling and Rating Using Active and Passive External Reconnaissance"
• U.S. Patent No. 10,944,795: "Rating Organization Cybersecurity Using Active and Passive External Reconnaissance"
• U.S. Patent No. 10,560,483: "Application of Advanced Cybersecurity Threat Mitigation to Rogue Devices, Privilege Escalation, and Risk-Based Vulnerability and Patch Management"
• U.S. Patent No. 10,735,456: "Advanced Cybersecurity Threat Mitigation Using Behavioral and Deep Analytics"
• U.S. Patent No. 10,248,910: "Detection Mitigation and Remediation of Cyberattacks Employing an Advanced Cyber-Decision Platform"
• U.S. Patent No. 10,210,255: "Distributed System for Large Volume Deep Web Data Extraction"
• U.S. Patent No. 10,204,147: "System for Capture, Analysis and Storage of Time Series Data from Sensors with Heterogeneous Report Interval Profiles"
• U.S. Patent No. 10,860,962: "System for Fully Integrated Capture, and Analysis of Business Information Resulting in Predictive Decision Making and Simulation"

This extensive family illustrates a concerted effort by Qomplx to secure broad protection for its cybersecurity and risk analytics platform. The numerous patents and applications in this family provide a strong foundation for the company's intellectual property position and are a key asset in their ongoing litigation efforts.